Thoughtful Investing to Advance Biopharmaceutical Innovation

Avoro Capital is a global life sciences investment firm with a focus on supporting emerging biotechnology companies.

Home

Innovation

1:3

We are intellectually curious and seek scientific breakthroughs that have the potential to address unmet medical needs.

Comprehensive Approach

2:3

Our goal is to identify unique or mispriced investment opportunities. We embrace the challenge to dissect complex situations, and provide companies with financial and intellectual support over the investment’s lifecycle.

Risk Management

3:3

We are vigilant in assessing macro and company-specific risks. Our portfolio construction strategy may include tactical and fundamental hedges, while sizing and liquidity considerations are carefully weighed.

Avoro, by definition, represents our core philosophy around “the support of progress”. The biotechnology sector is undergoing a period of unprecedented transformation. The vast need to efficiently address various diseases and to advance novel therapies to remediate unmet medical needs continues to drive innovative approaches by regulators, large pharma and entrepreneurial firms. This activity fosters an environment where large pharma firms are proactively seeking growth opportunities via partnerships and M&A, rendering assets with differentiating characteristics highly valuable.

Thoughtful Investing to Advance Biopharmaceutical Innovation

Home

Innovation

Comprehensive Approach

Risk Management

Contact Us

Site Map